The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Virupaksha Organics Ltd

Virupaksha Organics Limited, part of the promoter/promoter group of Oxygenta Pharmaceutical, acquired 20,00,000 shares (5.41%) of the company. The disclosure filed under Regulation 29(1) of SEBI's SAST Regulations, 2011 shows the acquirer's holding went from 18,477,458 shares (49.96%) to roughly 20,477,458 shares (about 55.37%) of the target company listed on BSE. No encumbrance or pledge details were involved — this is a straightforward equity acquisition. The promoter group has now firmly crossed the 50% majority holding threshold.